Nearly a third of the negative events, the device presented late (BDX: NYSE)

Nearly a third of the negative events of the medical devices have not been presented to the Food and Drug Administration in a 30 -day organizational framework, with most of the late reports submitted more than six months after the manufacturer’s notifications, according to the last research published in BMJ.

the